CapWealth Advisors’s Avanos Medical AVNS Stock Holding History

CapWealth Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,039	Closed	-$36K	–	104
2016 Q3	$36K	Sell	1,039 -112	-10%	-$3.92K	0.01%	152
2016 Q2	$37K	Sell	1,151 -111	-9%	-$3.4K	0.01%	154
2016 Q1	$36K	Sell	1,262 -83	-6%	-$2.21K	0.01%	152
2015 Q4	$45K	Sell	1,345 -15	-1%	-$466	0.01%	123
2015 Q3	$39K	Sell	1,360 -4,751	-78%	-$166K	0.01%	125
2015 Q2	$247K	Sell	6,111 -369	-6%	-$16.6K	0.06%	69
2015 Q1	$319K	Sell	6,480 -76	-1%	-$3.52K	0.08%	73
2014 Q4	$298K	Buy	+6,556	New	+$258K	0.07%	74

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

CapWealth Advisors's AVNS Position: Q4 2016 in Review

CapWealth Advisors sold out of Avanos Medical (AVNS) in Q4 2016, closing a stake of 1,039 shares — an estimated $36K sold.

CapWealth Advisors first reported a position in AVNS in Q4 2014 and held it in 8 quarters. The position peaked at $319K in Q1 2015. 360 funds tracked by Wall St. Rank hold AVNS as of Q4 2016.

CapWealth Advisors reported no remaining Avanos Medical position as of Q4 2016 after selling out during the quarter.
CapWealth Advisors sold 1,039 Avanos Medical shares in Q4 2016, an estimated $36K.
CapWealth Advisors first reported a position in Avanos Medical in Q4 2014 and held it in 8 quarters.
CapWealth Advisors's Avanos Medical position peaked at $319K in Q1 2015.
360 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2016.

Based on CapWealth Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.